Loading...
•
Sep 30, 2022
Cross Country Healthcare Q3 2022 Earnings Report
Cross Country Healthcare's third quarter performance exceeded expectations, driven by advanced technology and strong execution amidst normalizing market conditions.
Key Takeaways
Cross Country Healthcare reported strong Q3 2022 results, exceeding updated guidance ranges for revenue, Adjusted EBITDA, and Adjusted EPS. The company saw double-digit year-over-year revenue growth across both segments and repurchased 1 million shares of common stock. Consolidated revenue was $636.1 million, a 70% increase year-over-year, and net income attributable to common stockholders was $34.8 million.
Revenue, Adjusted EBITDA, and Adjusted EPS exceeded previously updated guidance ranges.
Double-digit year-over-year revenue growth was achieved across both segments.
Adjusted EBITDA margin was 10.0%.
1 million shares of common stock were repurchased for $24.3 million.
Revenue by Segment
Forward Guidance
The company provided guidance for Q4 2022, expecting revenue between $590 million and $600 million, a gross profit margin between 22.3% and 22.8%, Adjusted EBITDA between $52.0 million and $57.0 million, and Adjusted EPS between $0.85 and $0.95.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...